MMA Embolization for Refractory Chronic Migraine

Recruiting now · Not applicable

Conditions studied: Migraine Disorders

In brief

This is a prospective, multi-center, feasibility study to investigate safety and effectiveness of TRUFILL n-BCA liquid embolic system in bilateral middle meningeal artery (MMA) embolization for the treatment of refractory chronic migraine.

Key facts

Study ID

NCT06735833

Run by

Cerenovus, Part of DePuy Synthes Products, Inc.

People needed

70

Starts

2025-04-23

Expected to finish

2029-07-31

Last updated by the study team

2026-07-06

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

• West Virginia University — Morgantown, West Virginia, United States (enrolling)
• Stony Brook University Medical Center — Stony Brook, New York, United States (enrolling)
• Thomas Jefferson University Hospital — Philadelphia, Pennsylvania, United States (enrolling)
• Semmes Murphey Foundation — Memphis, Tennessee, United States (enrolling)
• Hartford Hospital — Hartford, Connecticut, United States (enrolling)
• Mount Sinai — New York, New York, United States (enrolling)
• John Muir Physician Network Clin. Research Center — Walnut Creek, California, United States
• Barrow Neurological Institute at St. Joseph's Hospital — Phoenix, Arizona, United States
• University of Buffalo Medical Center — Buffalo, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.